UNSPSC 85521831: Supplement hemiazygos vein with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement hemiazygos vein with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05U13KZ

UNSPSC 85521831 Supplement hemiazygos vein with nonautologous tissue substitute, percutaneous approach is a Commodity code that shows no relevant recent activity in state and local procurement. The code describes a specific surgical procedure, yet the six recent state and local opportunities posted in the 2026 window—covering independent medical evaluation services, health plan surgery benefit carve-outs, occupational medical surveillance, youth detention healthcare, pharmacy benefit management, and temporary health professional staffing—bear no connection to vascular surgical intervention or implantable tissue substitutes. The mismatch between the code's nominal scope and the actual work being solicited suggests either miscoding at the issuing level or absence of genuine procurement demand under this Commodity in the current state and local market.

State and local procurement activity under this code should not be pursued at this time based on available evidence. Business development professionals evaluating this UNSPSC should treat it as inactive for state and local government contracting purposes and redirect resources to code families or classes with demonstrable recent solicitation volume.